Arkadiusz Rudawski, PhD posted this:
Technology Broker at Center for Technology Transfer, Cracow University of Technology
Covid-19 Innovation Challenges by Innoget posted this:Expertise in molecular biology either experimentally or computationallyThe Institut de Biotecnologia i de Biomedicina (IBB) was created in 1970 as a research institute of the Universitat Autònoma de Barcelona (UAB) to promote fundamental biological research. In the year 2000, the focus of research evolved towards the Biotechnology and Biomedicine fields, with the aim of advancing scientific findings into translational results. At present, the Institute hosts 18 research groups organised into 3 programmes and working in 7 areas of expertise: • Bioinformatics • Cellular Biology • Structural Biology • Genomics • Immunology • Microbiology • Proteomics. This multidisciplinary character, one of the most relevant characteristics of the IBB, allows for a broad approach to biological problems, both basic and applied. The IBB is also highly engaged in academic training at the undergraduate and postgraduate levels.
TEC Edmonton posted this:Inhibitors of Viral Infectivity: Amphipathic Nucleoside Derivatives as Fusion InhibitorsA series of small pharmacological molecules have been discovered to be potent and non-cytotoxic inhibitors of viral fusion. The inhibitors act on the non-virally encoded lipids in the virion envelope. These molecules are rigid amphipathic compounds of inverted cone shape which locate to the outer leaflets of virion envelopes, creating a physical barrier to viral envelope and cell membrane fusion. These amphipathic nucleoside derivatives can serve as potential antiviral or therapeutic agents against herpes, HIV, influenza, hepatitis B & C, poxvirus and other DNA or RNA enveloped viruses. They can potentially be used as prophylactic ingredients in creams, lotions, gels and as antiviral disinfectants.
Covid-19 Innovation Challenges by Innoget posted this:Inhibitors of Viral Infectivity: Amphipathic Nucleoside Derivatives as Fusion InhibitorsA series of small pharmacological molecules have been discovered to be potent and non-cytotoxic inhibitors of viral fusion. The inhibitors act on the non-virally encoded lipids in the virion envelope. These molecules are rigid amphipathic compounds of inverted cone shape which locate to the outer leaflets of virion envelopes, creating a physical barrier to viral envelope and cell membrane fusion. These amphipathic nucleoside derivatives can serve as potential antiviral or therapeutic agents against herpes, HIV, influenza, hepatitis B & C, poxvirus and other DNA or RNA enveloped viruses. They can potentially be used as prophylactic ingredients in creams, lotions, gels and as antiviral disinfectants.
Pascal Mayer posted this:
CEO at Alphanosos
Alex Michine posted this:
CEO at MetGen
Universitat Politècnica de Catalunya - UPC posted this:Enzymatic aqueous preparation for the surface functionalization of paper or cellulosic substratesA new biotechnological product for the chemical modification of the surface of cellulosic substrates has been patented. The bioproduct is obtained from an enzyme-mediator system, and several properties can be easily conferred to substrates applying very low concentrations of this enzymatic product in their surface. Partners to further develop the product and/or to establish commercial agreements along with technical cooperation are sought.
Technology Transfer OfficeView Profile
Ivan Rodriguez Rosello posted this:
Licensing Manager at Universidad de Alicante
Consejo Superior de Investigaciones Científicas posted this:Isolation of the unsaponifiable fraction from oils and minor compoundsmmeeaassuurreemmeenntt The Spanish Research Council (CSIC) has developed a method to isolate the unsaponifiable fraction of fats and oils using a supported liquid extraction (SLE) column, its later purification with preparative HPLC and its characterization and quantification using gas chromatography (GC). This new procedure implies an important improvement regarding the current methods. Companies of the instrumental analytical chemistry field (scientific and technological equipment) are being sought to collaborate through a patent licence agreement. An offer for Patent Licensing
University of Vigo posted this:New non-destructive method for “in situ” monitoring of anticorrosive protection of organic coatingsThe main novelty of the device and procedure is the new portable sensor adaptable to virtually any surface. The device, fixable by vacuum to the surface under study, makes possible the measurement of the electrochemical interfacial impedance, that is the main parameter of interest for adherence quality and anti-corrosion performance.
University of Vigo posted this:Procedure for the extraction of biosurfactants contained in corn steep liquorsNowadays, most of the pharmaceutical and cosmetic products in the market contain chemically synthesized surfactants in its composition. In many cases, these surfactants are the same as those used in regular cleanup activities. In order to get more natural and biocompatible products, it would be interesting to include natural surfactants instead of chemical surfactants in the preparation of these pharmaceutical and cosmetic products. These biosurfactants are also present in the formulation of greener nanoparticles, replacing the chemical surfactants currently used in the preparation thereof. Most biosurfactants have antimicrobial activity, which would improve the properties of certain nanoparticles, as well as many pharmaceutical and cosmetic products. The main disadvantage of biosurfactants industrial production is related to the high cost compared to chemically synthesized surfactant production. The solution proposed by the Chemical Engineering research group at the University of Vigo, is the development of eco-friendly simple extraction of biosurfactant from a corn wet-milling industry byproduct, such as corn wash liquors, better known as "corn steep liquor (CSL)", which could compete in terms of cost production with its chemical counterparts.
University of Vigo posted this:A novel mild and efficient method to prepare ε-Caprolactam precursor of Nylon 6ε-Caprolactam, the main precursor of the synthetic fibber Nylon 6, is prepared from cyclohexanone oxime by treatment with a new salt as promoter. This procedure requires mild reaction conditions and affords excellent levels of conversion and selectivity to obtain pure ε-caprolactam. No reaction by-products are formed. The new promoter salt is cheap, no corrosive, and easy to prepare. All these characteristics makes the procedure suitable for undustrial purposes.
UACOOPERA University of Aveiro posted this:
Technology Transfer Office at uacoopera
Consejo Superior de Investigaciones Científicas posted this:Immunoassay for rapid diagnosis of infectious diseases caused by Pseudomonas aeruginosa CSIC, CIBER-BBN and UAB have developed an immunochemical method for diagnosis of infections produced by Pseudomonas aeruginosa. The immunoassay is fast and efficient, with low LOD and adaptable to point-of care devices.